Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Positive allosteric modulation of the mu-opioid receptor produces analgesia with reduced side effects
Ram Kandasamy, Todd M. Hillhouse, Kathryn E. Livingston, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 16
Open Access | Times Cited: 56

Showing 1-25 of 56 citing articles:

Structure-based design of bitopic ligands for the µ-opioid receptor
Abdelfattah Faouzi, Haoqing Wang, Saheem A. Zaidi, et al.
Nature (2022) Vol. 613, Iss. 7945, pp. 767-774
Closed Access | Times Cited: 82
Understanding and countering opioid‐induced respiratory depression
Jordan T. Bateman, Sandy E. Saunders, Erica S. Levitt
British Journal of Pharmacology (2021) Vol. 180, Iss. 7, pp. 813-828
Open Access | Times Cited: 64
A µ-opioid receptor modulator that works cooperatively with naloxone
Evan S. O’Brien, Vipin Ashok Rangari, Amal El Daibani, et al.
Nature (2024) Vol. 631, Iss. 8021, pp. 686-693
Closed Access | Times Cited: 14
Structural and dynamic insights into the activation of the μ-opioid receptor by an allosteric modulator
Shun Kaneko, Shunsuke Imai, Tomomi Uchikubo‐Kamo, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 8
Strategies towards safer opioid analgesics—A review of old and upcoming targets
Balázs R. Varga, John M. Streicher, Susruta Majumdar
British Journal of Pharmacology (2021) Vol. 180, Iss. 7, pp. 975-993
Open Access | Times Cited: 48
μ-Opioid Receptor (Oprm1) Copy Number Influences Nucleus Accumbens Microcircuitry and Reciprocal Social Behaviors
Carlee Toddes, Emilia M. Lefevre, Dieter D. Brandner, et al.
Journal of Neuroscience (2021) Vol. 41, Iss. 38, pp. 7965-7977
Open Access | Times Cited: 35
Activation mechanism of the μ-opioid receptor by an allosteric modulator
Shun Kaneko, Shunsuke Imai, Nobuaki Asao, et al.
Proceedings of the National Academy of Sciences (2022) Vol. 119, Iss. 16
Open Access | Times Cited: 22
Opioids and opioid receptors; understanding pharmacological mechanisms as a key to therapeutic advances and mitigation of the misuse crisis
David G. Lambert
BJA Open (2023) Vol. 6, pp. 100141-100141
Open Access | Times Cited: 15
Ketamine and Major Ketamine Metabolites Function as Allosteric Modulators of Opioid Receptors
Ivone Gomes, Achla Gupta, Elyssa B. Margolis, et al.
Molecular Pharmacology (2024) Vol. 106, Iss. 5, pp. 240-252
Closed Access | Times Cited: 5
Advances in the structural understanding of opioid allostery
Nokomis Ramos‐Gonzalez, Balázs R. Varga, Susruta Majumdar
Trends in Pharmacological Sciences (2025)
Open Access
Kratom Alkaloids as Probes for Opioid Receptor Function: Pharmacological Characterization of Minor Indole and Oxindole Alkaloids from Kratom
Soumen Chakraborty, Rajendra Uprety, Amal EI Daibani, et al.
ACS Chemical Neuroscience (2021) Vol. 12, Iss. 14, pp. 2661-2678
Open Access | Times Cited: 28
A promising chemical series of positive allosteric modulators of the μ-opioid receptor that enhance the antinociceptive efficacy of opioids but not their adverse effects
Kerri D. Pryce, Hye Jin Kang, Farhana Sakloth, et al.
Neuropharmacology (2021) Vol. 195, pp. 108673-108673
Open Access | Times Cited: 28
Structure–Activity Relationship Study of Cannabidiol-Based Analogs as Negative Allosteric Modulators of the μ-Opioid Receptor
Taryn Bosquez-Berger, Jessica A. Gudorf, Charles P. Kuntz, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 14, pp. 9466-9494
Closed Access | Times Cited: 12
Signaling Modulation Mediated by Ligand Water Interactions with the Sodium Site at μOR
Rohini S. Ople, Nokomis Ramos‐Gonzalez, Qiongyu Li, et al.
ACS Central Science (2024) Vol. 10, Iss. 8, pp. 1490-1503
Open Access | Times Cited: 4
Endogenous opiates and behavior: 2021
Richard J. Bodnar
Peptides (2023) Vol. 164, pp. 171004-171004
Closed Access | Times Cited: 9
Opioid modulation of prefrontal cortex cells and circuits
Rebecca H. Cole, Khaled Moussawi, Max E. Joffe
Neuropharmacology (2024) Vol. 248, pp. 109891-109891
Open Access | Times Cited: 3
Atypical opioid receptors: unconventional biology and therapeutic opportunities
Christie B. Palmer, Max Meyrath, Meritxell Canals, et al.
Pharmacology & Therapeutics (2021) Vol. 233, pp. 108014-108014
Open Access | Times Cited: 23
Mechanism of opioid addiction and its intervention therapy: Focusing on the reward circuitry and mu‐opioid receptor
Jia‐Jia Zhang, Changgeng Song, Jimin Dai, et al.
MedComm (2022) Vol. 3, Iss. 3
Open Access | Times Cited: 14
Bivalent and bitopic ligands of the opioid receptors: The prospects of a dual approach
Marie Emilie Hovah, Ulrike Holzgrabe
Medicinal Research Reviews (2024) Vol. 44, Iss. 6, pp. 2545-2599
Open Access | Times Cited: 2
Discovery of a mu-opioid receptor modulator that in combination with morphinan antagonists induces analgesia
Yihan Huang, Shu‐Yu Lin, Li‐Chin Ou, et al.
Cell chemical biology (2024) Vol. 31, Iss. 11, pp. 1885-1898.e10
Closed Access | Times Cited: 2
Novel role of the Mu-opioid receptor in pancreatic cancer: potential link between opioid use and cancer progression
Muhammad R. Haque, Usman Barlass, Andrew Armstrong, et al.
Molecular and Cellular Biochemistry (2022) Vol. 477, Iss. 5, pp. 1339-1345
Closed Access | Times Cited: 12
Biased, Bitopic, Opioid–Adrenergic Tethered Compounds May Improve Specificity, Lower Dosage and Enhance Agonist or Antagonist Function with Reduced Risk of Tolerance and Addiction
Robert Root‐Bernstein
Pharmaceuticals (2022) Vol. 15, Iss. 2, pp. 214-214
Open Access | Times Cited: 11
Peptidomimetics and Their Applications for Opioid Peptide Drug Discovery
Yeon Sun Lee
Biomolecules (2022) Vol. 12, Iss. 9, pp. 1241-1241
Open Access | Times Cited: 11
IUPHAR review: Recent progress in the development of Mu opioid receptor modulators to treat opioid use disorders
Piyusha P. Pagare, Rachael Flammia, Yan Zhang
Pharmacological Research (2023) Vol. 199, pp. 107023-107023
Open Access | Times Cited: 6
Beauty and Uncertainty as Transformative Factors: A Free Energy Principle Account of Aesthetic Diagnosis and Intervention in Gestalt Psychotherapy
Pietro Sarasso, Gianni Francesetti, Jan Roubal, et al.
Frontiers in Human Neuroscience (2022) Vol. 16
Open Access | Times Cited: 10
Page 1 - Next Page

Scroll to top